2026 ICD-10-CM Diagnosis Code T52.4X2AToxic effect of ketones, intentional self-harm, initial encounter
T52.4X2A is a billable ICD-10-CM diagnosis code for toxic effect of ketones, intentional self-harm, initial encounter. The 7th character A marks it as an initial encounter code, used while the patient is receiving active treatment. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 917 through 918. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under External cause codes: intent of injury, self-harm; External cause codes: poisoning by non-drug; and Suicidal ideation/attempt/intentional self-harm.
Code Identity
Code Classification
Coding GuidelinesGuidance
The appropriate 7th character is to be added to each code from block Toxic effect of organic solvents (T52). Use the following options for the applicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Table of Drugs and ChemicalsClinical
Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.
| Substance | Accidental | Self-harm | Assault | Undetermined | Adverse Effect | Underdosing |
|---|---|---|---|---|---|---|
| Acetone (oils) | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Acetone (oils)::chlorinated | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Acetone (oils)::vapor | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Acetophenone | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Butanone, 2-butanone | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Cyclohexanone | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Diacetone alcohol | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Hexanone, 2-hexanone | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Hexone | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Hydroxymethylpentanone | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Ketols | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Ketone oils | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| MEK (methyl ethyl ketone) | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::acetate | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::acetone | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::acrylate | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::alcohol | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::aminophenol | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::amphetamine | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::androstanolone | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::atropine | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::benzene | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::benzoate | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::benzol | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::bromide (gas) | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::bromide (gas)::fumigant | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::butanol | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::carbinol | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::carbonate | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::CCNU | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::cellosolve | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::cellulose | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::chloride (gas) | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::chloroformate | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::cyclohexane | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::cyclohexanol | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::cyclohexanone | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::cyclohexyl acetate | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::demeton | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::dihydromorphinone | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::ergometrine | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::ergonovine | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::ethyl ketone | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::glucamine antimonate | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::hydrazine | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::iodide | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::isobutyl ketone | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::isothiocyanate | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::mercaptan | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::morphine NEC | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::nicotinate | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::paraben | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::parafynol | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::parathion | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::peridol | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::phenidate | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::prednisolone | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::prednisolone::ENT agent | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::prednisolone::ophthalmic preparation | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::prednisolone::topical NEC | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::propylcarbinol | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::rosaniline NEC | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::salicylate | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::sulfate (fumes) | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::sulfate (fumes)::liquid | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::sulfonal | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::testosterone | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
| Methyl::thiouracil | T52.4X1 | T52.4X2 | T52.4X3 | T52.4X4 | – | – |
Convert T52.4X2A to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About T52.4X2AOverview
Is T52.4X2A (Toxic effect of ketones, intentional self-harm) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report toxic effect of ketones, intentional self-harm, initial encounter on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What does the 7th character A in T52.4X2A mean?
The final character A marks the initial encounter: use it while the patient is receiving active treatment for toxic effect of ketones, intentional self-harm, such as an emergency visit or first evaluation.
What MS-DRG does T52.4X2A group to?
When toxic effect of ketones, intentional self-harm, initial encounter is the principal diagnosis on an inpatient stay, it groups to MS-DRG 917, 918, with relative weights from 0.8571 to 1.5684 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of T52.4X2A?
Under the General Equivalence Mappings, toxic effect of ketones, intentional self-harm, initial encounter converts to ICD-9-CM 982.8 (toxic eff nonpetrol solv) and E950.9 (poison-solid/liquid NEC). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.
